Log in to save to my catalogue

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 – a retros...

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 – a retros...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8efdc14aa42e449d990100564e0ed8b3

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 – a retrospective cross-sectional study

About this item

Full title

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 – a retrospective cross-sectional study

Publisher

England: BioMed Central Ltd

Journal title

BMC medical research methodology, 2022-01, Vol.22 (1), p.23-23, Article 23

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

During the COVID-19 pandemic, the scientific world is in urgent need for new evidence on the treatment of COVID patients. The reporting quality is crucial for transparent scientific publication. Concerns of data integrity, methodology and transparency were raised. Here, we assessed the adherence of observational studies comparing treatments of COVI...

Alternative Titles

Full title

Poor reporting quality of observational clinical studies comparing treatments of COVID-19 – a retrospective cross-sectional study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8efdc14aa42e449d990100564e0ed8b3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8efdc14aa42e449d990100564e0ed8b3

Other Identifiers

ISSN

1471-2288

E-ISSN

1471-2288

DOI

10.1186/s12874-021-01501-9

How to access this item